Serum Levels of Interleukin-6 and Tumor Necrosis Factor-Alpha in Renal Anomalies and Diseases in Children
- 27 September 2025
- book chapter
- Published by Springer Nature
- p. 48-55
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosisEBioMedicine, 2022
- Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in childrenCochrane Database of Systematic Reviews, 2020
- Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in childrenJournal of Microbiology, Immunology and Infection, 2014
- The pro- and anti-inflammatory properties of the cytokine interleukin-6Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- The IL-6 −174G/C polymorphism and renal scarring in children with first acute pyelonephritisPediatric Nephrology, 2010
- Urinary interleukin-6 is useful in distinguishing between upper and lower urinary tract infectionsPediatric Nephrology, 2007
- Biological and clinical effects of anti-TNFα treatmentAutoimmunity Reviews, 2007
- Proinflammatory cytokines and procalcitonin in children with acute pyelonephritisPediatric Nephrology, 2005
- Mediators of fibrosis and apoptosis in obstructive uropathiesCurrent Urology Reports, 2005
- Associations between circulating inflammatory markers and residual renal function in CRF patientsAmerican Journal of Kidney Diseases, 2003